NCT03337958

Brief Summary

Chronic obstructive pulmonary disease (COPD) is a public health problem with great morbidity. The main therapeutic strategy is inhalers. The objective of this study is to determine the efficacy of an educational intervention in the use of inhalers in patients with COPD including ventilatory re-education and video recordings of the patients themselves.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for not_applicable chronic-obstructive-pulmonary-disease

Timeline
Completed

Started Dec 2017

Shorter than P25 for not_applicable chronic-obstructive-pulmonary-disease

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 20, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 9, 2017

Completed
22 days until next milestone

Study Start

First participant enrolled

December 1, 2017

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2018

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2018

Completed
Last Updated

July 12, 2018

Status Verified

July 1, 2018

Enrollment Period

7 months

First QC Date

September 20, 2017

Last Update Submit

July 11, 2018

Conditions

Keywords

EducationDry Powder InhalersMetered Dose InhalersPulmonary DiseaseChronic Obstructive

Outcome Measures

Primary Outcomes (1)

  • Respiratory parameters

    Changes from baseline to postintervention in respiratory parameters using a spirometer. The most important respiratory parameters evaluated is forced expiratory volume in the first second (FEV1)

    baseline, 12 months

Secondary Outcomes (9)

  • Knowledge of the disease

    Baseline, 12 months

  • Cognitive Level

    Baseline

  • Functional independence

    Baseline

  • Anxiety-depression level

    Baseline

  • Adhesion to inhalers

    Baseline

  • +4 more secondary outcomes

Study Arms (2)

CONTROL GROUP

NO INTERVENTION

Received the standard medical and pharmacological care provided by the hospital

INTERVENTION GROUP

EXPERIMENTAL

The group received the standard medical and pharmacological care provided by the hospital. In addition, an educational program on the use of inhalers, which included an explanation of the use of inhalers together with a ventilatory re-education program, furthermore, the technique of inhaler use was trained.

Device: Ventilatory re-education

Interventions

The first day of intervention consisted primarily in ventilatory re-education. During the realization of the technique he was videotaped with a Tablet so that later the patient could be seen and on the video to be able to give him the guidelines for the correction. On the second and third day of the intervention, ventilation re-education was performed and the inhalation technique was subsequently trained.

INTERVENTION GROUP

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Physical Therapy

Granada, 18071, Spain

RECRUITING

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveLung Diseases

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Marie Carmen Valenza, PT, PhD

    Universidad de Granada

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Marie Carmen Valenza, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: A randomized clinical trial.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

September 20, 2017

First Posted

November 9, 2017

Study Start

December 1, 2017

Primary Completion

June 15, 2018

Study Completion

July 1, 2018

Last Updated

July 12, 2018

Record last verified: 2018-07

Locations